107 related articles for article (PubMed ID: 19996816)
1. Risk prediction in pediatric cancer patients with fever and neutropenia.
Hakim H; Flynn PM; Srivastava DK; Knapp KM; Li C; Okuma J; Gaur AH
Pediatr Infect Dis J; 2010 Jan; 29(1):53-9. PubMed ID: 19996816
[TBL] [Abstract][Full Text] [Related]
2. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
3. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
Rondinelli PI; Ribeiro Kde C; de Camargo B
J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
[TBL] [Abstract][Full Text] [Related]
4. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of guideline for treatment of febrile neutropenia in pediatric cancer at Siriraj Hospital.
Sanpakit K; Phuakpet K; Veerakul G; Narkbunnam N; Chokephaibulkit K
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S124-34. PubMed ID: 16858853
[TBL] [Abstract][Full Text] [Related]
6. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
Hodgson-Viden H; Grundy PE; Robinson JL
BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
[TBL] [Abstract][Full Text] [Related]
7. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
[TBL] [Abstract][Full Text] [Related]
8. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
[TBL] [Abstract][Full Text] [Related]
9. Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Mosso C; O'Ryan M; Payá E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
Pediatr Infect Dis J; 2007 Sep; 26(9):794-8. PubMed ID: 17721373
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Enríquez N; O'Ryan M; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
Clin Infect Dis; 2002 Sep; 35(6):678-83. PubMed ID: 12203164
[TBL] [Abstract][Full Text] [Related]
11. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
[TBL] [Abstract][Full Text] [Related]
12. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
Agyeman P; Aebi C; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Beck Popovic M; Leibundgut K; Bodmer N; Ammann RA
Pediatr Infect Dis J; 2011 Jul; 30(7):e114-9. PubMed ID: 21394050
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
14. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?
Wicki S; Keisker A; Aebi C; Leibundgut K; Hirt A; Ammann RA
Pediatr Blood Cancer; 2008 Dec; 51(6):778-83. PubMed ID: 18726920
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
[TBL] [Abstract][Full Text] [Related]
16. [Febrile neutropenia in the child with cancer. Current concepts about risk assessment and selective management].
Santolaya ME
Rev Med Chil; 2001 Dec; 129(12):1449-54. PubMed ID: 12080883
[TBL] [Abstract][Full Text] [Related]
17. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
El Saleeby CM; Somes GW; DeVincenzo JP; Gaur AH
Pediatrics; 2008 Feb; 121(2):235-43. PubMed ID: 18245413
[TBL] [Abstract][Full Text] [Related]
19. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation.
Talcott JA; Finberg R; Mayer RJ; Goldman L
Arch Intern Med; 1988 Dec; 148(12):2561-8. PubMed ID: 3196123
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment and treatment of low-risk patients with febrile neutropenia.
Kern WV
Clin Infect Dis; 2006 Feb; 42(4):533-40. PubMed ID: 16421798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
